Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy

Authors :: Katjana S. Schwab
Glen Kristiansen
Alexander Isaak
Stefanie E. A. Held
Annekristin Heine
Peter Brossart
Source :: Frontiers in Oncology, Vol 9 (2019)
Publication Year :: 2019
Publisher :: Frontiers Media S.A., 2019.

Subjects :: nivolumab ipilimumab
head neck cancer
immunotherapy
Takotsubo cardiomyopathy (TTC)
cardiac toxicity
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Full Text Access

Tools